Fact CheckerSign in

NCT06732349Recruiting

Urinary Tubular Biomarkers for Chronic Kidney Disease

Source: ClinicalTrials.gov · Last updated 7 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Currently used tests for chronic kidney injury only assess the function of one part of the kidney: the filter called the glomerulus. The other part, called the tubule, is disregarded. Based on many previous studies, the investigators have good reason to assume that a better prediction of the course of chronic kidney disease by testing tubular function will be possible. This is important, for example, when patients need to be treated with kidney-protecting drugs.

Status (registry)
Recruiting
Study type
Observational
Enrollment
556 (estimated)
First submitted
10 Dec 2024
Start date
1 Jan 2025
Primary completion date
Dec 2029
Lead sponsor
Erasmus Medical Center
NCT number
NCT06732349

What you commit to

  • Study type: Observational
  • Planned participants: 556
  • From 1 Jan 2025 to the primary completion date, Dec 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Active glomerulonephritis treated with immunosuppression
  • Kidney transplant recipient
  • Current treatment with chemo- or immunotherapy for malignancy

Who the study is looking for

  • Chronic kidney disease stage 3 (eGFR 30-59ml/min)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Erasmus MC
Coordinator of this site? Confirm its status
RotterdamNetherlandsRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.